|
Treatment Effect and Resistance Profiles Were Similar Between Black/African American and Non-Black/African American Patients Treated with a Telaprevir Combination Regimen
|
|
|
Reported by Jules Levin
Presented at ACG - October 31, 2011
Andrew J. Muir, James C. Sullivan, Geoffrey M. Dusheiko, Michael W. Fried, Rajender Reddy, David R. Nelson, Natalie H. Bzowej, Tara L. Kieffer, Nathalie Adda, Christopher I. Wright, Leif Bengtsson, Shelley George and Steven L. Flamm. On behalf of the ADVANCE and ILLUMINATE Study Teams
|
|
|
|
|
|
|